LAMA2 and peripheral neuropathy: The patient had clinical manifestations of LGMD R23, such as increased CK levels, epilepsy, typical widespread abnormal white matter hyperintensities on T2-MRI found in LAMA2-MD (Figures 5E, F), and peripheral neuropathy.